SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Aardvark Adventures -- Ignore unavailable to you. Want to Upgrade?


To: ~digs who wrote (1190)7/14/2005 5:30:47 PM
From: ~digs  Respond to of 7944
 
update: CCC ended down 13% on heavy volume
stockcharts.com[w,a]daclyiay[pc40!c200!f][vc60][iut!La12,26,9!Ll14]&pref=G

9:22AM Calgon Carbon guides Q2 EPS and revs below consensus (CCC) 10.25 :Co issues downside guidance for Q2 (Jun), sees EPS of $0.06-0.08 vs. $0.10 Reuters Estimates consensus; sees Q2 (Jun) revs of Approximately $96 ml vs. $97.25 mln consensus.



To: ~digs who wrote (1190)8/6/2005 10:00:31 PM
From: ~digs  Read Replies (1) | Respond to of 7944
 
update: ASGN 6.3
stockcharts.com[w,a]daclyiay[pc40!c200!f][vc60][iut!La12,26,9!Ll14]&pref=G

SECOND QUARTER HIGHLIGHTS

* Revenues for the quarter totaled $57,408,000, up 24.0% year over year
and above the Company's previously announced estimates. Lab Support
segment revenues were up 18.2%, Medical Financial & Allied (MF&A)
revenues were up 43.5% and Nurse Travel revenues were up 23.4% versus
the second quarter of 2004.

* Gross margin for the quarter was 26.7%, an improvement of 70 basis
points (bps) year over year.

* Selling, General & Administrative expenses (SG&A) were down $418,000
to $15,556,000 from the previous quarter.

* Net income for the quarter was $146,000, including an income tax
benefit of $240,000, an improvement of $3,017,000 from the preceding
quarter's net loss.

* Cash, cash equivalents, restricted cash and marketable securities
totaled $25,673,000 at June 30, 2005, an increase of $2,862,000 from
the preceding quarter.